CMS Industry Report 2024: Medical Schemes Face Financial Strain
The CMS Industry Report 2024 reveals a surge in healthcare costs and an ageing population, forcing a shift in medical scheme strategies.
Pandemic Preparedness and Prevention: South Africa’s New Shield
Discover how Pandemic Preparedness and Prevention efforts in South Africa aim to improve bio-surveillance and health security.
Generic Lenacapavir Manufacturing: SA’s Bold 2027 Strategy
South Africa aims to begin generic Lenacapavir manufacturing by 2027. Read how the government plans to scale local production.
Mediclinic Restructuring Deal: Remgro and MSC to Split Assets
Remgro and MSC announce a Mediclinic restructuring deal that splits Southern African and Swiss assets to streamline healthcare operations.
GLP-1 Medicines Review: South Africa Moves to Expand Access
NEMLC begins a GLP-1 medicines review to assess affordability and potential inclusion in the public health sector for diabetes and obesity
HIV Treatment Retention: South Africa’s Plan for 1.1m Patients
SA faces a crisis in HIV treatment retention as 1.1 million patients disengage from care. The "Close the Gap" campaign aims to fix this.